Enhancement of the in vivo persistence and antitumor efficacy of CD19 chimeric antigen receptor T cells through the delivery of modified TERT mRNA

Mostrar otras versiones (1)
Detalles Bibliográficos
Autores principales: Bai, Yun, Kan, Shifeng, Zhou, Shixin, Wang, Yuting, Xu, Jun, Cooke, John P, Wen, Jinhua, Deng, Hongkui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Corrigendum
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004231/
https://www.ncbi.nlm.nih.gov/pubmed/27625791
http://dx.doi.org/10.1038/celldisc.2016.32

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5004231/
https://www.ncbi.nlm.nih.gov/pubmed/27625791
http://dx.doi.org/10.1038/celldisc.2016.32

Ejemplares similares